CREDIT NUMBER 7092-RW GRANT NUMBER E022-RW Financing Agreement (Third Additional Financing for the COVID-19 Emergency Response Project) between REPUBLIC OF RWANDA and INTERNATIONAL DEVELOPMENT ASSOCIATION CREDIT NUMBER 7092-RW GRANT NUMBER E022-RW FINANCING AGREEMENT AGREEMENT dated as of the Signature Date between REPUBLIC OF RWANDA (“Recipient”) and INTERNATIONAL DEVELOPMENT ASSOCIATION (“Association”) for the purpose of providing additional financing for the Original Project and activities related to the Original Project, as amended. The Recipient and the Association hereby agree as follows: ARTICLE I — GENERAL CONDITIONS; DEFINITIONS 1.01. The General Conditions (as defined in the Appendix to this Agreement) apply to and form part of this Agreement. 1.02. Unless the context requires otherwise, the capitalized terms used in this Agreement have the meanings ascribed to them in the General Conditions or in the Appendix to this Agreement. ARTICLE II — FINANCING 2.01. The Association agrees to extend to the Recipient a grant and a credit, which are deemed as Concessional Financing for purposes of the General Conditions (collectively, “Financing”) in the following amounts to assist in financing the project described in Schedule 1 to this Agreement (“Project”): (a) an amount equivalent to eleven million five hundred thousand Special Drawing Rights (SDR 11,500,000) (“Grant”); and (b) the amount of fourteen million three hundred thousand (€14,300,000) (“Credit”). 2.02. The Recipient may withdraw the proceeds of the Financing in accordance with Section III of Schedule 2 to this Agreement. 2.03. The Maximum Commitment Charge Rate is one-half of one percent (1/2 of 1%) per annum on the Unwithdrawn Financing Balance. 2.04. The Service Charge is the greater of: (a) the sum of three-fourths of one percent (3/4 of 1%) per annum plus the Basis Adjustment to the Service Charge; and (b) three-fourths of one percent (3/4 of 1%) per annum; on the Withdrawn Credit Balance. 2.05. The Payment Dates are May 1 and November 1 in each year. -2- 2.06. The principal amount of the Credit shall be repaid in accordance with the repayment schedule set forth in Schedule 3 to this Agreement. 2.07. The Payment Currency is Euro. ARTICLE III — PROJECT 3.01. The Recipient declares its commitment to the objective of the Project and the MPA Program. To this end, the Recipient shall carry out the Project through the Project Implementing Entity in accordance with the provisions of Article V of the General Conditions and Schedule 2 to this Agreement. ARTICLE IV — EFFECTIVENESS; TERMINATION 4.01. The Additional Conditions of Effectiveness consist of the following: (a) The Recipient has updated the ESMF in accordance with Section I.E.6 of Schedule 2 to this Agreement. (b) The Recipient has recruited a social risks management specialist and an environmental risks management specialist in accordance with Section I.A.4(a) of Schedule 2 to this Agreement. 4.02 The Effectiveness Deadline is the date sixty (60) days after the Signature Date. 4.03. For purposes of Section 10.05 (b) of the General Conditions, the date on which the obligations of the Recipient under this Agreement (other than those providing for payment obligations) shall terminate is twenty (20) years after the Signature Date. ARTICLE V — REPRESENTATIVE; ADDRESSES 5.01. The Recipient’s Representative is its Minister of Finance and Economic Planning. 5.02. For purposes of Section 11.01 of the General Conditions: (a) the Recipient’s address is: Ministry of Finance and Economic Planning 12 KN 3 Avenue P.O Box 158 Kigali, Rwanda; and (b) the Recipient’s Electronic Address is: Telex: E-mail: 250-252-577-581 info@minecofin.gov.rw -3- 5.03. For purposes of Section 11.01 of the General Conditions: (a) The Association’s address is: International Development Association 1818 H Street, N.W. Washington, D.C. 20433 United States of America; and (b) the Association’s Electronic Address is: Telex: Facsimile: 248423 (MCI) 1-202-477-6391 -4- AGREED as of the Signature Date. REPUBLIC OF RWANDA By _____________________________________/s1/ Authorized Representative Dr. Uzziel Ndagijimana Name: __________________________/n1/ Minister of Finance and Economic Planning Title: __________________________/t1/ 07-Apr-2022 Date: __________________________/d1/ INTERNATIONAL DEVELOPMENT ASSOCIATION By _____________________________________/s2/ Authorized Representative Rolande Pryce Name: __________________________/n2/ Country Manager Title: __________________________ /t2/ 06-Apr-2022 Date: __________________________ /d2/ -5- SCHEDULE 1 Project Description The objective of the Project is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in the Republic of Rwanda. The Project constitutes a phase of the MPA Program, and consists of the following parts: Part 1: Case Detection, Confirmation and Contact Tracing Enhancing case detection, disease surveillance, sample collection and ensuring rapid laboratory diagnoses and carrying out contact tracing for COVID-19 and other disease outbreaks through financing and support for: (a) enhancement of case detection through: (i) screening travelers at ports of entry as well as in priority communities and targeted health facilities; (ii) diagnosing cases and referring them for treatment as needed; (iii) carrying out contact tracing to minimize risk of transmission; (iv) conducting risk assessments to identify hot spot areas of transmission and provide timely information to policymakers including digital maps that can help in visualization of transmission; and (v) carrying out multi- sectoral simulation exercises for COVID-19 and other disease outbreaks; and (b) strengthening the health system through; inter alia: (i) providing medical supplies and equipment (e.g. thermo scanners; test kits; drugs; lab equipment and supplies, personal protective equipment); (ii) Training and capacity building for frontline workers; and (iii) Operating Costs for rapid response teams and recruitment of additional personnel. Part 2: Public Health Measures and Clinical Care Capacity Strengthening of public health policies and measures and establishment of critical clinical care capacity including promotion of digital solutions through financing and support for: (a) public health policies regarding: (i) social distancing measures (such as restrictions on border crossings, work-at-home policies, restricting public gatherings); (ii) personal hygiene promotion, including handwashing and proper cooking; (iii) risk communication and community engagement using local channels to disseminate messages about the risks associated with COVID-19 and other disease outbreaks and applying innovative -6- digital solutions such as mobile apps for sending out messages; (iv) production and dissemination of communication materials (including in digital form) and national and local campaigns to raise awareness; and (v) enhancement of data analytics capability to improve targeting and measure effectiveness; (b) provision of clinical care through: (i) establishment of isolation capacity at a selected number of national and district hospitals including the rehabilitation of existing structures and leveraging of isolation units established for other infectious diseases; (ii) providing health personnel with appropriate protective equipment and hygiene materials; (iii) support for provision of medical and laboratory equipment and supplies, waste management equipment and supplies and video conferencing equipment for tele-medicine; (iv) minor civil works (mainly refurbishments); and (v) including recruitment of additional clinical personnel; (c) purchase of Project COVID-19 Vaccines including assistance to support the Recipient’s advance purchase mechanisms; (d) deployment of Project COVID-19 Vaccines including support for: (i) Training of health providers, and other personnel responsible for the delivery, storage, handling, transportation, tracking and safety of Project COVID-19 vaccines; (ii) conducting assessments to inform the deployment of Project COVID-19 vaccines; (iii) strengthening the policy environment through production of guidelines, standard operating procedures and protocols; (iv) reinforcing the regulatory capacity of the Rwanda FDA to expedite the registration and approval processes in line with acceptable procedures and requirements; (v) planning and coordination of the Project COVID-19 vaccine deployment; and (vi) strengthening health care waste management and occupational health; (e) vaccine communication campaign including support to the PIE to: (i) conduct well targeted communication campaigns to increase awareness, foster demand, and address hesitancy through mass media, , social media and community outreach campaigns; (ii) track and monitor correct knowledge of COVID-19 vaccines, and identify views, perceptions, attitudes in order to continually improve implementation strategies and tailor communications; and (iii) facilitate citizen engagement mechanisms for feedback, accountability, grievance, citizen and community engagement; (f) screening high-risk groups through support for: (i) conducting community sensitization and mobilization to encourage people to be screened and vaccinated; (ii) screening for conditions that elevate the risk of COVID- 19; and (iii) referral and initial treatment for these conditions; -7- (g) oxygen therapy through purchase of: (i) basic respiratory therapy equipment and supplies that support climate safe technologies; and (ii) climate-smart technologies for district hospitals located in remote, rural areas and medicalized health centers operating in high population density locations; and (h) health system strengthening through: (i) acquisition of an international vaccination status monitoring system; (ii) acquisition of cold chain equipment; (iii) acquisition of mechanical ventilation system for vaccines warehouse; (iv) acquisition of refrigerated vehicles to support countrywide vaccine distribution; (v) acquisition of smoke-free incinerators for COVID-19 and vaccination waste management; (vi) acquisition and installation of a solar energy system to support continuous energy supply to the Nyamata Emerging Infectious Disease Isolation and Treatment Center; and (vii) acquisition of preventive and curative medical equipment. Part 3: Implementation Management and Monitoring and Evaluation Financing and support for: (a) Project management including: (i) strengthening of public structures for the coordination and management of the Project, including central and local (decentralized) arrangements for the coordination of Project activities (this will include support for the COVID-19 Incident Management System Coordination Structure); (ii) the carrying out of financial management and procurement requirements of the Project; and (iii) Project coordination activities; and (b) monitoring and evaluation of the Project including: (i) assessment of implementation progress and review of operational plans; (ii) technical assistance; and (iii) COVID-19 vaccination specific monitoring and evaluation, including: (A) training CHWs on surveillance activities and related COVID-19 testing; (B) strengthening capacity of districts and sectors to conduct vaccine related surveillance activities; (C) conducting disease surveillance to monitor the impact of the vaccination program and make corrections during implementation; (D) monitoring coverage and safety; (E) evaluating effectiveness and impact; and (F) providing vaccination certificates to all people vaccinated. -8- Part 4: Contingency Emergency Response Component (CERC) Providing immediate response to an Eligible Emergency, as needed. Part 5: Protecting Essential Health Services Strengthening and protecting essential health and nutrition services through financing and support for: (a) outreach activities and catch up campaigns for immunization and reproductive, maternal and child health services; (b) nutrition commodities; (c) organizing transport systems for patients and health providers; (d) Performance-based Payments to Eligible Community-based Health Workers (CHWs) to incentives CHWs to enhance awareness, mobilize the population and conduct basic screening for both reproductive, maternal, newborn and child health (RMNCH) and COVID-19; (e) building capacity of health providers and CHWs to use innovative technologies and approaches for delivering essential health services; (f) testing a new multi-disciplinary competence-based approach to the delivery of services by CHWs; (g) strengthening the health resources tracking system and promote interoperability for improved data visualization and analytics and enhanced data for decision making, including Geographical Information System tools; (h) screening for chronic conditions (such as hypertension and diabetes) using innovative strategies that leverage RMNCH services, including during community mobilization campaigns, couple screening during antenatal care visits or pre-conception care visits and/or workplace programs; and (i) performing periodic monitoring of the impact of COVID-19 on essential health and nutrition services and institutionalize the production of monthly and quarterly reporting. -9- SCHEDULE 2 Project Execution Section I. Implementation Arrangements A. Institutional Arrangements 1. The Recipient shall designate the MoH with overall oversight and responsibility for providing policy and strategic advice for the Project. 2. Coronavirus National Joint Taskforce (a) The Recipient shall maintain, at all times during the implementation of the Project, the Coronavirus National Joint Taskforce (“Taskforce”) with composition, powers, functions, facilities and other resources satisfactory to the Association. (b) The Taskforce shall coordinate the national response and provide strategic guidance during Project implementation. The Taskforce shall be assisted by an expert advisory team and the COVID-19 Command Post. 3. COVID-19 Command Post (a) The Recipient shall maintain, at all times during the implementation of the Project, the COVID-19 Command Post (“Command Post”), with composition, powers, functions, facilities and other resources satisfactory to the Association. (b) The Command Post shall report to the Taskforce with respect to overall workplan implementation status, results framework update, procurement plan status, risk management plan and escalate implementation bottlenecks for prompt decision and recommendation of remedial actions by the Taskforce. (c) The planning cell of the Command Post shall also: (i) review the Project Reports which shall be approved by the Command Post coordinator, (ii) approve the work plan and budget for the Project, and (iii) monitor performance and budget execution. 4. Rwanda Biomedical Center (a) The Recipient shall maintain throughout Project implementation the Rwanda Biomedical Center Single Project Implementation Unit (“RBC- SPIU”), with adequate resources and facilitation, key staff holding such qualifications and under terms of reference acceptable to the Association, -10- such staff to include a designated project focal point, a dedicated procurement specialist, financial management specialist or accountant, social risks management specialist and an environmental risks management specialist and any other technical and fiduciary specialists as may be agreed with the Association in the future and as further detailed in the Project Implementation Manual (“PIM”). (b) The RBC-SPIU shall be responsible for: (i) overall Project management; (ii) financial management under the Project; including flow of funds to different stakeholders; (iii) procurement of goods, medical and laboratory equipment and supplies; (iv) securing consultant services; (v) oversight of social and environmental risks management: and (vi) perform such other functions as may be further detailed in the PIM. B. Project Implementation Manual 1. The Recipient shall: (a) no later than thirty (30) days after the Effective Date, prepare a revised and updated project implementation manual containing detailed arrangements and procedures for implementation of the Project including inter alia: (i) administration and coordination; (ii) monitoring and evaluation; (iii) financial management, procurement and accounting procedures; (iv) environmental and social risks management; (v) corruption and fraud mitigation measures; (vi) a grievance redress mechanism; (vii) Personal Data collection and processing in accordance with the Ministry of Health’s Standard Operating Procedures for Management of Routine Health Information at Referral/Provincial and District Hospitals (Public and Privates) and in accordance with applicable national law and good international practice (including Personal Data in connection with distribution or delivery of vaccines and monitoring vaccination activities); (viii) roles and responsibilities for Project implementation; and (ix) such other arrangements and procedures as shall be required for the effective implementation of the Project; (b) furnish to and exchange views with the Association on such manual promptly upon its preparation, and consequently adopt such manual as shall have been approved in writing by the Association; and (c) thereafter implement the Project in accordance with the requirements set forth in the PIM. 2. The PIM shall not be amended, abrogated or any provision thereof waived unless the Association has provided its prior written ‘no-objection’. -11- 3. In the event of any conflict between the provisions of the PIM and those of this Agreement, the provisions of this Agreement shall prevail. C. Vaccine Delivery and Distribution Manual 1. Without limitation on Section I.B above, in order to ensure adequate implementation of Part 2 (c) to (h) of the Project, the Recipient shall update and adopt, a manual for COVID-19 Vaccine delivery and distribution (“Vaccine Delivery and Distribution Manual”), in form and substance satisfactory to the Association, which shall include: (a) rules and procedures for prioritizing intra-country vaccine allocation following principles established in the WHO Fair Allocation Framework, including an action plan setting out the timeline and steps for implementing such rules; (b) rules and procedures establishing minimum standards for vaccine management and monitoring, including medical and technical criteria, communications and outreach plan, cold chain infrastructure, and other related logistics infrastructure; (c) rules and procedures for processing and collection of Personal Data in accordance with national law on Personal Data Protection if it is deemed adequate and good international practice; (d) vaccine distribution plan, including action plan setting out timeline and steps for immunization; (e) vaccine safety monitoring, the management of adverse events following immunization (AEFI) and injection safety; and (f) procedures, protocols and measures to ensure that the Recipient’s vaccine program does not include forced vaccination. 2. The Recipient shall carry out the Project in accordance with this Agreement, the Project Implementation Manual, and the Vaccine Delivery and Distribution Manual. Except as the Association shall otherwise agree, the Recipient shall not assign, amend, abrogate, or waive the provisions of the Project Implementation Manual or the Vaccine Delivery and Distribution Manual without prior approval of the Association. In the event of any conflict between the provisions of the Project Implementation Manual or Vaccine Delivery and Distribution Manual and this Agreement, the provisions of this Agreement shall prevail. -12- D. Work Plans and Budget 1. The Recipient shall no later than thirty (30) days after the Effective Date: (a) prepare and furnish to the Association a proposed work plan and budget (“WPB”) for Project implementation setting forth: (i) a detailed description of the planned activities, including any proposed conferences and Training, under the Project for the period covered by the plan; (ii) the sources and proposed use of funds therefor; (iii) procurement and environmental and social risks management arrangements therefor, as applicable; and (iv) responsibility for the execution of said Project activities, budgets, start and completion dates, outputs and monitoring indicators to track progress of each activity; (b) taking into account the Association’s comments, finalize the plan and furnish it to Association for its approval; and (c) adopt the plan as shall have been approved by the Association. 2. The Recipient shall ensure that the Project is implemented in accordance with the WPB. 3. The Recipient shall not make or allow to be made any change to the WPB without prior agreement in writing by the Association. 4. In the event of any conflict between the WPB and the provisions of this Agreement, the provisions of this Agreement shall prevail. E. Environmental and Social Standards 1. The Recipient shall ensure that the Project is carried out in accordance with the Environmental and Social Standards, in a manner acceptable to the Association. 2. Without limitation upon paragraph 1 above, the Recipient shall, and shall cause the Project Implementing Entity to, ensure that the Project is implemented in accordance with the Environmental and Social Commitment Plan (“ESCP”), in a manner acceptable to the Association. To this end, the Recipient shall ensure that: (a) the measures and actions specified in the ESCP are implemented with due diligence and efficiency, as provided in the ESCP; (b) sufficient funds are available to cover the costs of implementing the ESCP; (c) policies and procedures are maintained, and qualified and experienced staff in adequate numbers are retained to implement the ESCP, as provided in the ESCP; and (d) the ESCP, or any provision thereof, is not amended, repealed, suspended or waived, except as the Association shall otherwise agree in writing, as specified in the ESCP, and ensure that the revised ESCP is disclosed promptly thereafter. -13- 3. In case of any inconsistencies between the ESCP and the provisions of this Agreement, the provisions of this Agreement shall prevail. 4. The Recipient shall ensure that: (a) all measures necessary are taken to collect, compile, and furnish to the Association through regular reports, with the frequency specified in the ESCP, and promptly in a separate report or reports, if so requested by the Association, information on the status of compliance with the ESCP and the environmental and social instruments referred to therein, all such reports in form and substance acceptable to the Association, setting out, inter alia: (i) the status of implementation of the ESCP; (ii) conditions, if any, which interfere or threaten to interfere with the implementation of the ESCP; and (iii) corrective and preventive measures taken or required to be taken to address such conditions; (b) the Association is promptly notified of any incident or accident related to or having an impact on the Project which has, or is likely to have, a significant adverse effect on the environment, the affected communities, the public or workers, in accordance with the ESCP, the environmental and social instruments referenced therein and the Environmental and Social Standards; and (c) the Recipient shall establish, publicize, maintain and operate an accessible grievance mechanism, to receive and facilitate resolution of concerns and grievances of Project-affected people, and take all measures necessary and appropriate to resolve, or facilitate the resolution of, such concerns and grievances, in a manner acceptable to the Association. 5. The Recipient shall ensure that all bidding documents and contracts for civil works under the Project include the obligation of contractors, subcontractors and supervising entities to: (a) comply with the relevant aspects of ESCP and the environmental and social instruments referred to therein; and (b) adopt and enforce codes of conduct that should be provided to and signed by all workers, detailing measures to address environmental, social, health and safety risks, and the risks of sexual exploitation and abuse, sexual harassment and violence against children, all as applicable to such civil works commissioned or carried out pursuant to said contracts. 6. The Recipient shall update the ESMF, and subsequently adopt and disclose the updated ESMF, in a manner acceptable to the Association. -14- F. Standards for COVID-19 Vaccine Approval All Project COVID-19 Vaccines shall satisfy the Vaccine Approval Criteria. G. Contingent Emergency Response 1. In order to ensure the proper implementation of contingent emergency response activities under Part 4 of the Project (“Contingent Emergency Response Part”), the Recipient shall ensure that: (a) a manual (“CERC Manual”) is prepared and adopted in form and substance acceptable to the Association, which shall set forth detailed implementation arrangements for the Contingent Emergency Response Part, including: (i) any structures or institutional arrangements for coordinating and implementing the Contingent Emergency Response Part; (ii) specific activities which may be included in the Contingent Emergency Response Part, Eligible Expenditures required therefor (“Emergency Expenditures”), and any procedures for such inclusion; (iii) financial management arrangements for the Contingent Emergency Response Part; (iv) procurement methods and procedures for the Contingent Emergency Response Part; (v) documentation required for withdrawals of Financing amounts to finance Emergency Expenditures; (vi) a description of the environmental and social assessment and management arrangements for the Contingent Emergency Response Part; and (vii) a template Emergency Action Plan; (b) the Emergency Action Plan is prepared and adopted in form and substance acceptable to the Association; (c) the Emergency Response Part is carried out in accordance with the CERC Manual and the Emergency Action Plan; provided, however, that in the event of any inconsistency between the provisions of the CERC Manual or the Emergency Action Plan and this Agreement, the provisions of this Agreement shall prevail; and (d) neither the CERC Manual or the Emergency Action Plan is amended, suspended, abrogated, repealed or waived without the prior written approval by the Association. 2. The Recipient shall ensure that the structures and arrangements referred to in the CERC Manual are maintained throughout the implementation of the Contingent Emergency Response Part, with adequate staff and resources satisfactory to the Association. 3. The Recipient shall ensure that: -15- (a) the environmental and social instruments required for the Contingent Emergency Response Part are prepared, disclosed and adopted in accordance with the CERC Manual and the ESCP, and in form and substance acceptable to the Association; and (b) the Contingent Emergency Response Part is carried out in accordance with the environmental and social instruments in a manner acceptable to the Association. 4. Activities under the Contingency Emergency Response Part shall be undertaken only after an Eligible Crisis or Emergency has occurred. Section II. Project Monitoring, Reporting and Evaluation 1. The Recipient shall furnish to the Association each Project Report not later than forty-five (45) days after the end of each calendar semester, covering the calendar semester. 2. Except as may otherwise be explicitly required or permitted under this Agreement or as may be explicitly requested by the Association, in sharing any information, report or document related to the activities described in Schedule 1 of this Agreement, the Borrower shall ensure that such information, report or document does not include Personal Data. Section III. Withdrawal of the Proceeds of the Financing A. General Without limitation upon the provisions of Article II of the General Conditions and in accordance with the Disbursement and Financial Information Letter, the Recipient may withdraw the proceeds of the Financing to finance Eligible Expenditures; in the amount allocated and, if applicable, up to the percentage set forth against each Category of the following table: -16- Percentage of Amount of the Amount of Expenditures Credit the Grant to be Category Allocated Allocated Financed (expressed in (expressed (inclusive of EUR) in SDR) Taxes) (1) Goods, works, non- 14,300,000 11,500,000 100% consulting services, and consulting services for the Project (2) Emergency Expenditures 0 0 100% TOTAL AMOUNT 14,300,000 11,500,000 B. Withdrawal Conditions; Withdrawal Period 1. Notwithstanding the provisions of Part A above, no withdrawal shall be made: (a) for payments made prior to the Signature Date, except that withdrawals up to an aggregate amount not to exceed: (i) for the Credit: €5,000,500; and (ii) for the Grant: SDR 4,025,000; may be made for payments made prior to this date but in no case more than one (1) year prior to the Signature Date, for Eligible Expenditures; or (b) for Emergency Expenditures under Category (2), unless and until all of the following conditions have been met in respect of said expenditures: (i) (A) the Recipient has determined that an Eligible Crisis or Emergency has occurred, and has furnished to the Association a request to withdraw Financing amounts under Category (2); and (B) the Association has agreed with such determination, accepted said request and notified the Recipient thereof; and (ii) the Recipient has adopted the CERC Manual and Emergency Action Plan, in form and substance acceptable to the Association. 2. The Closing Date is June 30, 2025. -17- SCHEDULE 3 Repayment Schedule Principal Amount of the Date Payment Due Credit repayable (expressed as a percentage)* On each May 1 and November 1, commencing May 1, 1.5625% 2028 to and including November 1, 2059 * The percentages represent the percentage of the principal amount of the Credit to be repaid, except as the Association may otherwise specify pursuant to Section 3.05 (b) of the General Conditions. -18- APPENDIX Definitions 1. “AF 2 Financing Agreement” means the Financing Agreement for the second additional financing for the COVID-19 Emergency Response Project between the Republic of Rwanda and the Association, dated April 22, 2021 (Credit No. 6871- RW and Grant No. D805). 2. “Anti-Corruption Guidelines” means, for purposes of paragraph 5 of the Appendix to the General Conditions, the “Guidelines on Preventing and Combating Fraud and Corruption in Projects Financed by IBRD Loans and IDA Credits and Grants”, dated October 15, 2006 and revised in January 2011 and as of July 1, 2016. 3. “Basis Adjustment to the Service Charge” means the Association’s standard basis adjustment to the Service Charge for credits in the currency of denomination of the Credit, in effect at 12:01 a.m. Washington, D.C. time, on the date on which the Credit is approved by the Executive Directors of the Association, and expressed either as a positive or negative percentage per annum. 4. “Category” means a category set forth in the table in Section III.A of Schedule 2 to this Agreement. 5. “CERC Manual” means the manual referred to in Section G of Schedule 2 to this Agreement, as such manual may be updated from time to time with the agreement of the Association, and which is an integral part of the Project Implementation Manual. 6. “Contingent Emergency Response Part” means any activity or activities to be carried out under Part 4 of the Project to respond to an Eligible Crisis or Emergency. 7. “COVAX Facility” means the COVID-19 Vaccine Global Access Facility, a mechanism through which demand and resources are pooled to support the availability of, and equitable access to, COVID-19 vaccines for all economies, and which is coordinated by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the WHO. 8. “COVID-19” means the coronavirus disease caused by the 2019 novel coronavirus (SARS-CoV-2). 9. “Eligible CHWs” means community-based health workers that meet the respective eligibility criteria and conditions specified in the manual to be prepared by the Recipient for management of the Performance-based Payments under Part 5(d) of the Project. -19- 10. “Eligible Crisis or Emergency” means an event that has caused, or is likely to imminently cause, a major adverse economic and/or social impact to the Recipient, associated with a natural or man-made crisis or disaster. 11. “Emergency Action Plan” means the plan referred to in Section G.1.(a), detailing the activities, budget, implementation plan, and monitoring and evaluation arrangements, to respond to the Eligible Crisis or Emergency. 12. “Emergency Expenditures” means any of the eligible expenditures set forth in the CERC Manual referred to in Section G.1.(a) of Schedule 2 to this Agreement and required for the Contingent Emergency Response Part. 13. “Environmental and Social Commitment Plan” or “ESCP” means the environmental and social commitment plan for the Project, dated March 24, 2022, as the same may be amended from time to time in accordance with the provisions thereof, which sets out the material measures and actions that the Recipient shall carry out or cause to be carried out to address the potential environmental and social risks and impacts of the Project, including the timeframes of the actions and measures, institutional, staffing, training, monitoring and reporting arrangements, and any environmental and social instruments to be prepared thereunder. 14. “Environmental and Social Management Framework” or “ESMF” means the framework prepared and adopted by the Recipient for the Original Project and to be updated for this Project, in a manner acceptable to the Association, to be disclosed in-country, and on the Association’s website, setting out the principles, rules, guidelines and procedures to screen and assess the potential adverse environmental and social risks and impacts (including health and safety issues) of Project activities, adopt measures to avoid, reduce, mitigate or offset environmental and social adverse risks and impacts, procedural, budget and institutional arrangements and actions needed to implement these measures, and information on the agency or agencies responsible for addressing the Projects’ risks and impacts; as well as for the preparation of environmental and social management plans, such as an infection control and waste management plan, as such framework may be amended by the Recipient from time to time, with the prior written agreement of the Association. 15. “Environmental and Social Standards” or “ESSs” means, collectively: (i) “Environmental and Social Standard 1: Assessment and Management of Environmental and Social Risks and Impacts”; (ii) “Environmental and Social Standard 2: Labor and Working Conditions”; (iii) “Environmental and Social Standard 3: Resource Efficiency and Pollution Prevention and Management”; (iv) “Environmental and Social Standard 4: Community Health and Safety”; (v) “Environmental and Social Standard 5: Land Acquisition, Restrictions on Land Use and Involuntary Resettlement”; (vi) “Environmental and Social Standard 6: Biodiversity Conservation and Sustainable Management of Living Natural -20- Resources”; (vii) “Environmental and Social Standard 7: Indigenous Peoples/Sub- Saharan Historically Underserved Traditional Local Communities”; (viii) “Environmental and Social Standard 8: Cultural Heritage”; (ix) “Environmental and Social Standard 9: Financial Intermediaries”; (x) “Environmental and Social Standard 10: Stakeholder Engagement and Information Disclosure”; effective on October 1, 2018, as published by the Association. 16. “General Conditions” means the “International Development Association General Conditions for IDA Financing, Investment Project Financing”, dated December 14, 2018 (revised on August 1, 2020, April 1, 2021, and January 1, 2022). 17. “Ministry of Health” or “MoH” means the Recipient’s ministry responsible for health, or any successor thereto. 18. “MPA Program” means the multiphase programmatic approach program designed to assist countries in their efforts to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. 19. “Nyamata Emerging Infectious Disease Isolation and Treatment Center” means the Recipient’s center located at the Recipient’s Bugesera district (Eastern Province). 20. “Operating Costs” means the reasonable incremental expenses incurred by the Recipient, based on the Work Plan and Budget, on account of Project implementation, including costs related to audits, office equipment and supplies, vehicle operation and maintenance, shipping costs, office rentals, communication and insurance costs, office administration costs, bank charges, utilities, transport costs, travel, per diem and supervision costs, and salaries of contracted personnel, including reasonable hazard/indemnity pay, but excluding salaries of officials of the Recipient’s civil service. 21. “Original Financing Agreement” means the financing agreement for the COVID - 19 Emergency Response Project between the Republic of Rwanda and the Association, dated April 9, 2020 (Credit No. 6615-RW), as amended by the AF 2 Financing Agreement. 22. “Original Project” means the Project described in Schedule 1 to the Original Financing Agreement. 23. “Performance-based Payments” means the payments provided to Eligible CHWs under Part 5(d) of the Project in accordance with the eligibility criteria and conditions specified in the manual to be prepared by the Recipient for management of these payments for the purpose of incentivizing CHWs to enhance awareness, -21- mobilize the population and conduct basic screening for both reproductive, maternal, newborn and child health (RMNCH) and COVID-19. 24. “Personal Data” means any information relating to an identified or identifiable individual. An identifiable individual is one who can be identified by reasonable means, directly or indirectly, by reference to an attribute or combination of attributes within the data, or combination of the data with other available information. Attributes that can be used to identify an identifiable individual include, but are not limited to, name, identification number, location data, online identifier, metadata and factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of an individual. 25. “Procurement Regulations” means, for purposes of paragraph 85 of the Appendix to the General Conditions, the “World Bank Procurement Regulations for IPF Borrowers”, dated November 2020. 26. “Project COVID-19 Vaccine” means a vaccine for the prevention of COVID -19, authorized by the Borrower’s national regulatory authority for distribution, marketing and administration within the territory of the Borrower, and acquired or deployed under the Project; “Project COVID-19 Vaccines” means the plural thereof. 27. “Project Implementing Entity” or “PIE” means the Rwanda Biomedical Center. 28. “Rwanda Biomedical Center” or “RBC” means the Rwanda Biomedical Center (RBC) established and operating pursuant to Law Nº 013/2019 of 30/06/2019 governing Rwanda Biomedical Centre; or any successor thereto acceptable to the Association. 29. “Rwanda FDA” means the Rwanda Food and Drugs Authority established pursuant to the Recipient’s Law Nº 003/2018 of 09/02/2018 establishing the Rwanda Food and Drugs Authority; or any successor thereto acceptable to the Association. 30. “RBC-SPIU” means the single project implementation unit established within the Rwanda Biomedical Center and referred to in Section I.A.4(a) of Schedule 2 to this Agreement. 31. “Signature Date” means the later of the two dates on which the Recipient and the Association signed this Agreement and such definition applies to all references to “the date of the Financing Agreement” in the General Conditions. 32. “Stakeholder Engagement Plan” means the document to be prepared and adopted by the Recipient, satisfactory to the Association, disclosed in-country, and the Association’s website, setting out the principles, rules, guidelines, procedures and -22- timing of engagement with stakeholders throughout the life cycle of the Project as agreed between Association and the Recipient, and also describing the range and timing of information to be communicated to project-affected parties and other interested parties, as well as the type of information to be sought from them, as such document may be amended by the Recipient from time to time, with the prior written agreement of the Association. 33. “Stringent Regulatory Authority” means a National Regulatory Authority (“NRA”) that is classified by WHO as a Stringent Regulatory Authority. 34. “Training” means the reasonable costs associated with training under the Project, based on the Work Plan and Budget, and attributable to study tours, training courses, seminars, workshops and other training activities, not included under service providers’ contracts, including costs of training materials, space and equipment rental, travel, accommodation and per diem costs of trainees and trainers, trainers’ fees, and other training related miscellaneous costs. 35. “Vaccine Approval Criteria” means that the Project COVID-19 Vaccine: (a) has received regular or emergency licensure or authorization from at least one of the Stringent Regulatory Authorities identified by WHO for vaccines procured and/or supplied under the COVAX Facility, as may be amended from time to time by WHO; (b) has received the WHO Prequalification or WHO Emergency Use Listing; or (c) has met such other criteria as may be agreed in writing between the Recipient and the Association. 36. “Vaccine Delivery and Distribution Manual” means the Recipient’s manual referred to in Section I.C of Schedule 2 to this Agreement, as the same may be amended from time to time with the Association’s prior written approval. 37. “WHO Fair Allocation Framework” means the rules which govern the allocation of vaccines to participants in the COVAX Facility, as developed by WHO, subject to periodic review by the COVAX Facility. 38. “WHO Emergency Use Listing” means a risk-based procedure for assessing and listing by WHO of unlicensed vaccines, therapeutics, and in vitro diagnostics with the aim of expediting the availability of these products to people affected by a declared public health emergency. 39. “WHO Prequalification” means a service provided by WHO to assess the quality, safety, and efficacy of medical products for priority diseases, and which are intended for United Nations and international procurement to developing countries.